the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …

the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …

I examine the effect of pharmaceutical innovation on the functional status of nursing home residents using cross … of 50%. During the period 1990-2004, pharmaceutical innovation reduced the functional limitations of nursing home …

I examine the effect of pharmaceutical innovation on the functional status of nursing home residents using cross … have been 58%, instead of 50%. During the period 1990-2004, pharmaceutical innovation reduced the functional limitations of …